Bacteremia in a university hospital: Study of etioloqical aqents and their susceptibility patterns;Bacteriemias en un hospital universitario: Estudio de los agentes etiológicos y de sus patrones de sensibilidad

Revista Clinica Espanola

Volumn 199, Issue 8, 1999, Pages 503-510

  Betriu, C ^a   Palau, L ^a   Gomez M ^a   Sanchez A ^a   Romero, J ^a   Picazo, J J ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Bacteremia; Etiology; Incidence; Susceptibility patterns

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; AZTREONAM; CEFAZOLIN; CEFOTAXIME; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; GLYCOPEPTIDE; IMIPENEM; MACROLIDE; MEROPENEM; OXACILLIN; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; TOBRAMYCIN; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; ESCHERICHIA COLI; HEMATOLOGIC DISEASE; MINIMUM INHIBITORY CONCENTRATION; SOLID TUMOR; STAPHYLOCOCCUS AUREUS; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINOGLYCOSIDES; AMPICILLIN; AMPICILLIN RESISTANCE; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIA; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MICROBIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HOSPITALS, UNIVERSITY; HUMANS; INFANT; INFANT, NEWBORN; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PENICILLIN RESISTANCE; PENICILLINS; SPAIN; TETRACYCLINE RESISTANCE; TETRACYCLINES; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 0032828584     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. McCabe WR, Jacksons GG. Gram-negative bacteremia. I. Etiology and ecology. Arch Intern Med 1962; 110:847-855.
2. Myerowitz RL, Medeiros AA, O'Brien TF. Recent experience with bacillemia due to gram-negative organisms. J Infect Dis 1971; 124:239-246.
3. Singer C, Kaplan MH, Amstrong D. Bacteremia and fungemia complicating neoplastic disease. Am J Med 1977; 62:731-742.
4. EORTC International Antimicrobial Therapy Project Group. Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. J Infect Dis 1978; 137:14-29.
5. EORTC International Antimicrobial Therapy Cooperative Group. Ceftazidine combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. N Engl J Med 1987; 317:1.692-1.698.
6. Ispahani P, Pearson NJ, Greenwood D. An analysis of community and hospital-acquired bacteraemia in a large teaching hospital in the United Kingdom. Q J Med 1987; 63:427-440.
7. Scheckler WE, Scheibel W, Kresge D. Temporal trends in septicemia in a community hospital. Am J Med 1991; 91 (suppl 3B);90S-94S.
8. Stillman RI, Wenzael RP, Donowitz LC. Emergence of coagulase-negative staphylococci as a major nosocomial bloodstream pathogens. Infect Control 1987; 8:108-112.
9. EORTC International Antimicrobial Therapy Cooperative Group. Gram-positive bacteremia in granulocytopenic cancer patients. Eur J Cancer 1990; 26:569-574.
10. Geerdes HF, Ziegler D, Lode H, et al. Septicemia in 980 patients at a university hospital in Berlin: prospective studies during 4 selected years between 1979 and 1989. Clin Infect Dis 1992; 15:991-1.002.
11. Washington JA, and the International Collaborative Blood Culture Study Group. An internatioal multicenter study of blood culture practices. Eur J Clin Microbiol Infect Dis 1992; 11:1.115-1.128.
12. EORTC International Antimicrobial Therapy Cooperative Group. Efficacy and toxicity of single dialy dose of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infections in patients with cancer and granulocytopenia. Ann Intern Med 1993; 119:584-593.
13. Haug JB, Harthug S, Kalager T, Digranes A, Solberg CO. Bloodstream infections at a norwegian university hospital 1974-1979 and 1988-1989: changing etiology, clinical features, and outcome. Clin Infect Dis 1994; 19:246-256.
14. Rubio M, Palau L, Romero Vivas JR, et al. Predominance of gram-positive microorganisms as a cause of septicemia in patients with hematological malignancies. Infect Control Hosp Epidemiol 1994; 15:101-104.
15. Crowe M, Ispahani P, Humphreys M, Kelley T, Winter R. Bacteraemia in the adult intensive care unit of a teaching hospital in Nottingham. UK. 1985-1996. Eur J Clin Microbiol Infect Dis 1998; 17:377-384.
16. Berner R, Schumacher RF, Bartlet S, Forster J, Brandis M. Predisposing conditions and pathogens in bacteremia in hospitalized children. Eur J Clin Microbiol Infect Dis 1998; 17:337-340.
17. Pfaller MA, Jones RN, Doern GV, Kugler K, and the SENTRY participants group. Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Agents Chemother 1998; 42:1.762-1.770.
18. González-Barca E, Fernández-Sevilla A, Carratalá J, Grañena A, Gudiol F. Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution. Eur J Clin Microbiol Infect Dis 1996; 15:291-296.
19. Sjöberg I, Fredlund H. Survey of blood culture isolates in an area of Sweden from 1980 to 1986. Eur J Clin Microbiol Infect Dis 1988; 7:501-504.
20. Arpi M, Victor MA, Moller JK, et al. Changing etiology of bacteremia in patients with hematological malignancies in Denmark. Scand J Infect Dis 1994; 26:157-162.
21. Isenberg HD, Baron EJ, D'Amato RF, et al. Recommendations for the isolation of bacteria from clinical speciems. En: Ballows A, Hausler WJ, Hermann KL, Isenberg HD, Shadomy HJ, eds. Manual of Clinical Microbiology (4th ed). Washington, DC: American Society for Microbiology, 1991; 216-221.
22. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically (3rd ed). Approved standard. NCCLS document M7-A3. Villanova, Pensylvania: National Commitee for Clinical Laboratory Standards, 1993.
23. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing, sixth informational supplement. NCCLS document M100-S6. Villanova, Pensylvania: National Committee for Clinical Laboratory Standards, 1995.
24. Grupo de Estudio de la Bacteriemia. Bacteriemia en seis hospitales españoles. Med Clĩn (Barc) 1986; 86:221-232.
25. Matas L, Marti C, Morera MA, Sierra M, Vilamala A, Gorcoy F. Grupo de microbiólogos de hospitales comarcales de Catalunya. Bacteriemia en 13 hospitales generales de la provincia de Barcelona. Estudio prospectivo de 1.674 episodios. Enferm Infecc Microbiol Clin 1995; 13:345-355.
26. Vázquez F, Mendoza MC, Villar MH, Pérez F, Mendez FJ. Survey of bacteremia in a Spanish hospital over a decade (1981-1990). J Hosp Infect 1994; 26:111-121.
27. Trilla A, Gatell JM, Mensa J, et al. Risk factors for nosocomial bacteremia in a large Spanish teaching hospital: a case-control study. Infect Control Hosp Epidemiol 1991; 12:150-156.
28. Weinstein MP, Reller LB, Murphy JR, Lichtenstein KA. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis 1983; 5:33-53.
29. Setia U, Gross PA. Bacteremia in a community hospital: spectrum and mortality. Arch Intern Med 1977; 137:1.698-1.701.
30. Sota M, Ezpeleta C, Cisterna R. Bacteriemia: estudio multicéntrico español con 5,000 casos. Rev Clin Esp 1997; 197 (monográfico 5):3-9.
31. Kam KM, Luey KY, Fung SM, Yiu PP, Harden TJ, Cheung MM. Emergence of multiple-antibiotic-resistant Streptococcus pneumoniae in Hong Kong. Antimicrob Agents Chemother 1995; 39:2.667-2.670.
32. EPINE Working Group. Prevalence of hospital-acquired infections in Spain. J Hosp Infect 1992; 20:1-13.
33. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991; 91 (suppl 3B):725-755.
34. Dorsher CW, Rosenblatt JE, Wilson WR, Ilstrup DM. Anaerobic bacteremia decreasing rate over a 15-year period. Rev Infect Dis 1991; 13:633-636.
35. Paraino VA, Cross SA, Goldstein EJC. Incidence and clinical significance of anaerobic bacteremia in a community hospital. Clin Infect Dis 1993; 16 (suppl 4):288-291.
36. Bochud PY, Calandra T, Franciolli P. Bacteremia due to viridans streptococci in neutropenic patients: a review. Am J Med 1994; 97:256-264.
37. Cercenado E, Sánchez-Carrillo C, Alcalá L, Bouza E. Grupo de Trabajo para el Estudio de Estafilococos. Situación actual de la resistencia de Staphylococcus en España. Cuarto estudio nacional (1996). Rev Clín Esp 1997; (monográfico 2):18-24.
38. Goldstein FW, Coutrot A, Seifer A, Acar F. Percentages and distributions of teicoplanin and vancomycin-resistant strains among coagulase-negative staphylococci. Antimicrob Agents Chemother 1990; 34:899-900.
39. Cercenado E, García-Leoni ME, Sánchez C, Catalán P, Bernaldo de Quirós JCL, Bouza E. Emergence of teicoplanin-resistant coagulase-negative staphilococci. J Clin Microbiol 1996; 34:1.765-1.768.
40. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40:135-146.
41. CDC. Reduced susceptibility of Staphylococcus aureus to vancomycin-United States. MMWR 1997; 46:765-766.
42. CDC. Reduced susceptibility of Staphylococcus aureus to vancomycin-United States. MMWR 1997; 46:813-815.
43. Dornbusch K, and the European Study Group on Antibiotic Resistance. Resistance to β-lactam antibiotics and ciprofloxacin in gram-negative bacilli and staphylococci isolated from blood: a European collaborative study. J Antimicrob Chemother 1990; 26:269-278.
44. Archer GL, Climo MW. Antimicrobial susceptibility of coagulase-negative staphylococci. Antimicrob Agents Chemother 1994; 38:2.231-2.237.
45. CDC. Nosocomial enterococci resistant to vancomycin-United States, 1989-1993. MMWR 1993; 42:597-599.
46. Norris AH, Reilly JP, Edelstein PH, Brennan PJ, Schuster MG. Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections. Clin Infect Dis 1995; 20:1.137-1.144.
47. White W, Klare I. Glycopeptide resistant Enterococcus faecium outside hospitalss: a commentary. Microb Drugs Res 1995; 3:259-263.
48. Fenoll A, Martin Bourgnon C, Muñoz R, Vicioso D, Casal J. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989. Rev Infect Dis 1991; 13:56-60.
49. Nava JM, Bella F, Garau J, et al. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin Infect Dis 1994; 19:884-890.
50. Martínez-Martínez L, López-Hernández I, Pascual A, Suárez AI, Perea EJ. Resistance of Streptococcus pneumoniae to penicillin, erythromycin and third generation of cephalosporins in Seville, Southern Spain. Clin Microbiol Infect 1997; 3:382-385.
51. Pfaller MA, Jones RN, Marshall SA, Edmond MB, Wenzel RP. SCOPE Hospital Study Group. Nosocomial streptococcal blood stream infections in the SCOPE program: species occurrence and antimicrobial resistance. Diagn Microbiol Infect Dis 1997; 29:259-263.
52. Fasola E, Spangler SK, Ednie LM, Jacobs MR, Bajaksouzian S, Appelbaum PC. Comparative activities of LY 333328, a new glycopaptide, against penicillin-susceptible and resistant pneumococci. Antimicrob Agents Chemother 1996; 40:2.161-2.163.
53. Harbarth S, Rohner P, Safran E, Garbino J, Auckenthaler R, Pittet D. Resistance to amikacin among gram-negative bloodstream isolates in a university hospital between 1989 and 1994. Clin Microbiol Infect 1998; 4: 199-204.
54. Dornbusch K, Miller GH, Hare RS, Shaw KJ. and the ESGAR Study Group. Resistance to aminoglycoside-antibiotics in gram-negative bacilli and staphylococci isolated from blood. Report from a European collaborative study. J Antimicrob Chemother 1990; 26:131-144.
55. Sorensen TL, Frimodt-Moller N, Espersen F. Use of antimicrobials and resistance in bacteria isolated from blood cultures in a Danish county from 1992 to 1995. Clin Microbiol Infect 1998; 8:422-430.